Phase I study of everolimus (RAD001) and AMG 479 in patients (pts) with advanced solid tumors and colorectal cancer (CRC).

被引：0
|
作者：
Khawaja, M. R.
Younger, A.
Funke, J. M.
Waddell, M. J.
Jones, D. R.
Pollok, K.
Prasad, N. K.
Berry, W.
Sandusky, G.
Chiorean, E. G.
机构：
[1] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
[2] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA
[3] Indiana Univ, Indianapolis, IN 46204 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.tps157
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS157
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase I study of everolimus (E, RAD001) and ganitumab (G, AMG 479) in patients (pts) with advanced solid tumors.
    Jalal, Shadia Ibrahim
    Strother, Robert Matthew
    Sandusky, George
    Prasad, Nagendra K.
    Berry, William
    Jones, David R.
    Younger, Anne
    Funke, Jennifer M.
    Detty, Tammi
    Althouse, Sandra
    Perkins, Susan M.
    Chiorean, E. Gabriela
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] Phase I trial of patupilone (P) and RAD001 in patients (pts) with advanced solid tumors
    Stein, M. N.
    Knox, B.
    Wesolowsky, E.
    Levitt, M.
    Moss, R.
    Poplin, E.
    Mehnert, J.
    Gounder, M.
    Goodin, S.
    DiPaola, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [3] A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer
    Vlahovic, Gordana
    Meadows, Kellen L.
    Hatch, Ace J.
    Jia, Jingquan
    Nixon, Andrew B.
    Uronis, Hope E.
    Morse, Michael A.
    Selim, M. Angelica
    Crawford, Jeffrey
    Riedel, Richard F.
    Zafar, S. Yousuf
    Howard, Leigh A.
    O'Neill, Margot
    Meadows, Jennifer J.
    Haley, Sherri T.
    Arrowood, Christy C.
    Rushing, Christel
    Pang, Herbert
    Hurwitz, Herbert I.
    ONCOLOGIST, 2018, 23 (07): : 782 - 790
  • [4] Phase I study of sorafenib in combination with everolimus (RAD001) in patients with advanced neuroendocrine tumors
    Jennifer A. Chan
    Robert J. Mayer
    Nadine Jackson
    Paige Malinowski
    Eileen Regan
    Matthew H. Kulke
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1241 - 1246
  • [5] Phase I study of sorafenib in combination with everolimus (RAD001) in patients with advanced neuroendocrine tumors
    Chan, Jennifer A.
    Mayer, Robert J.
    Jackson, Nadine
    Malinowski, Paige
    Regan, Eileen
    Kulke, Matthew H.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (05) : 1241 - 1246
  • [6] Phase I Clinical and Pharmacokinetic Study of RAD001 (Everolimus) Administered Daily to Japanese Patients with Advanced Solid Tumors
    Okamoto, Isamu
    Doi, Toshihiko
    Ohtsu, Atsushi
    Miyazaki, Masaki
    Tsuya, Asuka
    Kurei, Katsutoshi
    Kobayashi, Ken
    Nakagawa, Kazuhiko
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (01) : 17 - 23
  • [7] Phase I study of sorafenib in combination with everolimus (RAD001) in patients with advanced neuroendocrine tumors (NET)
    Chan, J. A.
    Mayer, R. J.
    Jackson, N.
    Malinowski, P.
    Regan, E.
    Kulke, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Phase I Study of Sorafenib in Combination With Everolimus (RAD001) in Patients With Advanced Neuroendocrine Tumors (NET)
    Chan, Jennifer A.
    Mayer, Robert J.
    Jackson, Nadine
    Malinowski, Paige
    Regan, Eileen
    Kulke, Matthew H.
    PANCREAS, 2011, 40 (02) : 326 - 326
  • [9] Phase I study of pasireotide (SOM 230) and everolimus (RAD001) in advanced neuroendocrine tumors
    Chan, Jennifer A.
    Ryan, David P.
    Zhu, Andrew X.
    Abrams, Thomas A.
    Wolpin, Brian M.
    Malinowski, Paige
    Regan, Eileen M.
    Fuchs, Charles S.
    Kulke, Matthew H.
    ENDOCRINE-RELATED CANCER, 2012, 19 (05) : 615 - 623
  • [10] A phase I trial of RAD001 in combination with cetuximab in patients with advanced solid tumors
    Avadhani, A. N.
    Flaherty, K.
    Rosen, M.
    Veronese, M. L.
    Harlacker, K.
    Johnson, S. W.
    Sherman, E.
    Griggs, W.
    Divgi, C. R.
    O'Dwyer, P. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345